Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis
- PMID: 15623705
- DOI: 10.1212/01.wnl.0000147259.34163.33
Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis
Abstract
Antibodies against native glycosylated myelin-oligodendrocyte-glycoprotein (MOG) were measured by ELISA in patients with multiple sclerosis (MS) and controls. Anti-MOG IgM antibodies were elevated during the first demyelinating event. Higher MOG-specific IgG antibodies were found in patients during relapses and in secondary chronic progressive MS compared to patients in remission and healthy controls. Antibodies against native MOG may be a potential biomarker for MS.
Comment in
-
Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis.Neurology. 2005 Sep 13;65(5):781-2; author reply 781-2. doi: 10.1212/wnl.65.5.781-b. Neurology. 2005. PMID: 16157927 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources